Account Accounts payable Accounts receivable Accumulated amortization, patent Account Description Balance* $ 20,900 67,700 50,900 149,300 62,900 3,500 4,100 29,300 Accumulated depreciation, equipment Accumulated depreciation, vehicles Advertising payable Allowance for doubtful accounts Cash Common shares, 100,000 shares authorized; 25,000 shares were issued at an average price of $10.10; market price per share on March 31, 2020, was $11.30 Equipment Income tax payable Notes payable** Patent Prepaid rent Retained earnings Unearned revenues Vehicles *Assume that all accounts have normal balances. ? 473,000 55,700 149,000 115,700 55,700 ? 28,100 82,100 **$65,000 of the notes payable will be paid by March 31, 2021. Required: Using the information from the alphabetized post-closing trial balance above, prepare a classified balance sheet for Sassy Pharmaceuticals Inc. as at March 31, 2020. (Enter all amounts as positive values. Enter the balance sheet items in the order of liquidity.) SASSY PHARMACEUTICALS INC. Balance Sheet March 21 2020